Timing of Energy Availability on Menstrual Cycle Function
- Conditions
- Menstrual Irregularity
- Interventions
- Dietary Supplement: Artificially Sweetened BeverageDietary Supplement: Artificially Sweetened Carbohydrate Beverage
- Registration Number
- NCT06471582
- Lead Sponsor
- University of Colorado, Colorado Springs
- Brief Summary
The primary aim of this clinical trial is to evaluate how fasted prolonged exercise may influence circulating reproductive hormones (i.e., estradiol, progesterone, luteinizing hormone) and menstrual cycle length when energy availability is maintained at or above 30 kcal/kg lean body mass/ day among women who regularly do running or cycling exercise. A secondary aim is to determine the effects of fasted prolonged exercise on serum leptin and cortisol.
Participants will be asked to do the following over a \~3 month enrollment period:
* attend a laboratory visit at the beginning of the study to have their resting metabolic rate, aerobic fitness, and body composition tested
* monitor their menstrual cycle length, urine hormones, perceived stress levels, and diet for \~3 months
* complete 3, 90-minute exercise sessions on a stationary bike or treadmill either fed (consuming a carbohydrate meal 1 h prior and 0.7 g carbohydrate/ kg body mass/ h during exercise) or fasted (consuming no meal prior and no carbohydrates during exercise) during month \~3
* saliva samples will be taken prior to and after 90-minute exercise sessions for quantification of leptin and cortisol
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 64
- participates in structured running or cycling exercise for at least 30 minutes on 3 or more days per week
- accustomed to exercising for 90 minutes or more
- has regular periods every 21-35 days
- have not taken hormonal contraceptives for at least the past 6 months
- is not currently or trying to become pregnant or breastfeeding, and has not been pregnant or breastfeeding in the past 12 months
- does not currently have a diagnosis of a major menstrual cycle disorder (i.e., amenorrhea, polycystic ovary syndrome [PCOS], endometriosis, ovarian cancer, ovarian insufficiency, uterine or endometrial cancer)
- does not currently have a metabolic disease (i.e., hypothyroidism, hyperthyroidism, Cushing disease, Addison's disease, diabetes, congenital adrenal hyperplasia)
- does not currently have a major cardiovascular or respiratory disease
- miss more than 7 consecutive days of aerobic activity (i.e., running, cycling, cross training)
- demonstrate clinical low energy availability as defined as energy availability <30 kcal/kg fat free mass
- report menstrual cycle lengths <21 or >35 days in the first 2 months of at-home monitoring
- do not demonstrate an anticipated rise in luteinizing hormone and progesterone in the first 2 months of at-home monitoring
- begin taking a hormonal contraceptive
- become pregnant
- are diagnosed with a menstrual cycle disorder (i.e., amenorrhea, polycystic ovary syndrome [PCOS], endometriosis, ovarian cancer, ovarian insufficiency, uterine, or endometrial cancer)
- are diagnosed with a metabolic disease (i.e., hypothyroidism, hyperthyroidism, Cushing disease, Addison's disease, diabetes)
- are diagnosed with a major cardiovascular or respiratory disease
- are unable to follow instructions for any of the procedures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Fasted without Carbohydrates Artificially Sweetened Beverage Participants will complete 3, 90-minute stationary cycle or treadmill exercise sessions following an overnight fast. During exercise, they will consume an artificially sweetened beverage containing no carbohydrates. Fed with Carbohydrates Artificially Sweetened Carbohydrate Beverage Participants will complete 3, 90-minute stationary cycle or treadmill exercise sessions 1 h after consuming a meal containing 1 g carbohydrate/ kg body weight. During exercise, they will consume an artificially sweetened beverage containing 0.7 g carbohydrate/ kg body mass/ h as a 2:1 mixture of glucose and fructose.
- Primary Outcome Measures
Name Time Method Urinary estrone-3-glucuronide (E3G) 3 months ng/mL
Urinary pregnanediol glucuronide (PdG) 3 months ug/mL
Menstrual cycle length 3 months days
Urinary luteinizing hormone (LH) 3 months MIU/mL
- Secondary Outcome Measures
Name Time Method Salivary leptin 3 days ng/mL
Salivary cortisol 3 days ng/mL
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
William J. Hybl Sports Medicine and Performance Center
🇺🇸Colorado Springs, Colorado, United States